MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway

miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer

(2015) Peng Liu et al.   CANCER LETTERS

WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer

(2015) Annalucia Serafino et al.   Oncotarget

By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy

(2015) Annalisa Petrelli et al.   Oncotarget

miR-612 suppresses the stemness of liver cancer via Wnt/β-catenin signaling

(2014) Jun Tang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

miR-30-5p Functions as a Tumor Suppressor and Novel Therapeutic Tool by Targeting the Oncogenic Wnt/β-Catenin/BCL9 Pathway

(2014) Jian-Jun Zhao et al.   CANCER RESEARCH

MicroRNA-29a suppresses the growth, migration, and invasion of lung adenocarcinoma cells by targeting carcinoembryonic antigen-related cell adhesion molecule 6

(2014) Hye Sook Han et al.   FEBS LETTERS

MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis

(2014) S-H Chan et al.   ONCOGENE

MicroRNA-100 regulates pancreatic cancer cells growth and sensitivity to chemotherapy through targeting FGFR3

(2014) Zhipeng Li et al.   TUMOR BIOLOGY

miR-100 Induces Epithelial-Mesenchymal Transition but Suppresses Tumorigenesis, Migration and Invasion

(2014) Dahu Chen et al.   PLoS Genetics

MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2)

(2013) Meng-Tao Ma et al.   CANCER LETTERS

The Wnt/β-catenin pathway in ovarian cancer: A review

(2013) Rebecca C. Arend et al.   GYNECOLOGIC ONCOLOGY

Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma

(2013) Ping Chen et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Tumor-Initiating Cells and FZD8 Play a Major Role in Drug Resistance in Triple-Negative Breast Cancer

(2013) S. Yin et al.   MOLECULAR CANCER THERAPEUTICS

Pro-metastatic tumor–stroma interactions in breast cancer

(2012) Sharath Gangadhara et al.   Future Oncology

miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling

(2012) C A Gebeshuber et al.   ONCOGENE

Clinicopathological Significance and Prognostic Value of DNA Methyltransferase 1, 3a, and 3b Expressions in Sporadic Epithelial Ovarian Cancer

(2012) Xuefeng Bai et al.   PLoS One

Frizzled-8 as a putative therapeutic target in human lung cancer

(2011) Hua-qing Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia

(2011) Y-S Zheng et al.   ONCOGENE

Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome

(2010) Andrey I. Khramtsov et al.   AMERICAN JOURNAL OF PATHOLOGY

β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis

(2010) F. Klemm et al.   CARCINOGENESIS

Ancient animal microRNAs and the evolution of tissue identity

(2010) Foteini Christodoulou et al.   NATURE

Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases

(2009) Bryan T. MacDonald et al.   DEVELOPMENTAL CELL